Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorised
July 22, 2020

Coronavirus company news summary – BD receives additional orders for 177 million injection devices – AXIM develops Covid-19 test for neutralising antibodies

By Chloe Kent

ndd Medical Technologies has launched single patient-use, inline filters for its lung function testing devices. The filters are expected to offer additional safety amid the Covid-19 pandemic. The filters complement the EasyOne spirometry range, which includes the EasyOne Air, Pro, and Pro LAB.

BD has received additional orders for needles and syringes from the US and Canada that totals 177 million injection devices. In total, the company has received orders of 330 million needles and syringes from the US, Canada and the UK. Most of the orders are expected to be delivered by the end of this year, in expectation of the vaccine being approved later this year or early next year.

Medical Marijuana has announced that its investment company AXIM Biotechnologies has developed a rapid diagnostic test that measures the levels of functional neutralising antibodies that are said to prevent SARS-CoV-2 (Covid-19) infection. AXIM’s test takes ten minutes and measures the certain subpopulation of antibodies to prevent the coronavirus from attacking the body. The company has submitted the application for pre-Emergency Use Authorisation (EUA) with the US Food and Drug Administration (FDA).

PerkinElmer has launched a dry blood spot (DBS) based test for SARS-CoV-2 IgG that uses its GSP/DELFIA platform that enables the processing of around 5,000 samples daily. The test is marketed as a CE-IVD test and PerkinElmer aims to submit its application to the US Food and Drug Administration (FDA) for Emergency Use Authorization (EUA).

Related Companies

Content from our partners
Precision wire: The future of bespoke medical treatment
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
“This technique means everything to us”: How CGM devices empower users 

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU